Christos Ierna

Mr. Ierna's experience includes advising:

• General Catalyst on the €385 million Series A financing round of Mistral AI, a French start-up specializing in generative artificial intelligence
• Inari Medical in its acquisition of LimFlow
• ArchiMed Portfolio Company, Natus Medical Incorporated, in its acquisition of Micromed, a global provider of neurophysiology solutions
• Astorg Partners in its the binding agreement to acquisition ofre CordenPharma, a leading pharmaceutical contract development and manufacturing organization, from International Chemical Investors Group (ICIG)
• TA Associates in its acquisition of a majority growth investment in DL Software 
• Ardian in:
  • its acquisition of a majority stake in Inula Group, a France-based company that the develops, produces, and distributes phytotherapeutic remedies 
  • the sale of the Kersia group (global leader in biosecurity and food safety), other co-investors, and managers to IK Investment Partners 
• Atomico in its investment in Sorare’s Series B raise, the largest ever in the non-fungible token (NFT) space
• Körber, an international technology company, in the sale of a minority stake in its supply chain software business to KKR 
• SHD in the acquisition of a majority stake in Pragma Informatique